Comparison of postoperative immune function between da Vinci robot-assisted and video-assisted thoracoscopic surgery in patients with non-small cell lung cancer
- VernacularTitle:达芬奇机器人与电视胸腔镜手术对非小细胞肺癌患者术后免疫功能影响的对比研究
- Author:
Jialong XUE
1
,
2
;
Wei XU
3
;
Xingchi LIU
3
;
Bo LIU
3
;
Shiguang XU
3
;
Boxiao HU
3
;
Xiaokang GONG
3
;
Xu LI
3
;
Shumin WANG
3
Author Information
1. 1. Graduate Training Base of General Hospital of Northern Theater Command, Jinzhou Medical University, Shenyang, 110016, P.R.China
2. 2. Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang, 110016, P.R.China
3. Department of Thoracic Surgery, General Hospital of Northern Theater Command, Shenyang, 110016, P.R.China
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
da Vinci robot-assisted thoracoscopic surgery;
video-assisted thoracoscopic surgery;
immune function
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(05):534-539
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effect on postoperative immune function between da Vinci robot-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) , and to provide clinical support for more effective surgical procedures. Methods A total of 90 patients undergoing radical resection of pulmonary carcinoma in our hospital from June to November 2019 were included. There were 49 males and 41 females with an average age of 62.67 (37-84) years. Among them, 50 patients underwent da Vinci robot-assisted thoracoscopic surgery (a RATS group) and 40 patients underwent video-assisted thoracoscopic surgery (a VATS group). The perioperative indexes as well as postoperative inflammatory factors and immune level effects between the two groups were compared. Results Compared with the VATS, RATS could significantly shorten the operation time and decrease intraoperative blood loss (P<0.05). RATS also effectively reduced the increase of postoperative inflammatory factor level (P<0.05). But there was no significant difference in postoperative immune function between the RATS group and the VATS group (P>0.05). Conclusion RATS is superior to VATS in the treatment of non-small cell lung cancer in perioperative indicators and inflammatory factors.
